Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 AUD | +7.94% | -21.84% | 0.00% |
Apr. 24 | Next Science Product Sales Rise 19% to $5.5 Million for March Quarter | MT |
Apr. 24 | Transcript : Next Science Limited, Q1 2024 Earnings Call, Apr 24, 2024 |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bacterial Related Issues Technologies
100.0
%
| 17 | 100.0 % | 33 | 100.0 % | +97.77% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
98.5
%
| 16 | 94.0 % | 33 | 98.5 % | +107.15% |
Australia and New Zealand
1.5
%
| 1 | 6.0 % | 1 | 1.5 % | -49.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Myntti
FOU | Founder | - | 17-10-19 |
Harry Hall
CEO | Chief Executive Officer | - | 23-07-09 |
Marc Zimmerman
DFI | Director of Finance/CFO | - | 23-05-25 |
Jeanne Lee
CTO | Chief Tech/Sci/R&D Officer | - | 19-02-28 |
Jon Swanson
COO | Chief Operating Officer | - | 18-05-31 |
Françoise Dixon
IRC | Investor Relations Contact | - | - |
Michael Morello
PRN | Corporate Officer/Principal | - | 21-03-31 |
Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hall
CEO | Chief Executive Officer | - | 23-07-09 |
Grant Hummel
BRD | Director/Board Member | - | 23-08-22 |
Dan Spira
BRD | Director/Board Member | - | 17-05-31 |
Chairman | 62 | 18-09-30 | |
Katherine Ostin
BRD | Director/Board Member | - | 23-10-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 291,695,103 | 136,073,909 ( 46.65 %) | 0 | 46.65 % |
Company contact information
Sector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 64.68M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NXS Stock
- Company Next Science Limited